MOSAIC IMMUNOENGINEERING, INC. Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31)
MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) of -$67.78 thousand for the 3-month period ending 2019-02-28, per its 10-Q filed 2019-04-15.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems · last filed 2019-04-15
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2019-02-28 was -$67.78K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-11-30 was -$29.49K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-08-31 was -$29.56K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for the quarter ending 2018-02-28 was -$89.48K.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2015 was $146.95K, a 76.61% decline from fiscal 2014.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2014 was $628.35K, a 87.49% decline from fiscal 2013.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2013 was $5.02M.
- MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, income (loss) from continuing operations (deprecated 2020-01-31) for fiscal 2012 was -$3.64M.
| Period end | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|
| 2019-02-28 | -$67.78K 10-Q · filed 2019-04-15 | -$97.26K derived: sum of 2 quarters · filed 2019-04-15 | -$126.82K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | -$29.49K 10-Q · filed 2019-01-14 | -$59.05K 10-Q · filed 2019-01-14 | ||
| 2018-08-31 | -$29.56K 10-Q · filed 2018-10-15 | |||
| 2018-02-28 | -$89.48K 10-Q · filed 2019-04-15 | -$298.87K derived: sum of 2 quarters · filed 2019-04-15 | -$319.27K 10-Q · filed 2019-04-15 | |
| 2017-11-30 | -$209.38K 10-Q · filed 2019-01-14 | -$229.78K 10-Q · filed 2019-01-14 | ||
| 2017-08-31 | -$20.40K 10-Q · filed 2018-10-15 | |||
| 2017-02-28 | -$64.28K 10-Q · filed 2018-04-16 | $2.43M derived: sum of 2 quarters · filed 2018-04-16 | $2.32M 10-Q · filed 2018-04-16 | |
| 2016-11-30 | $2.49M 10-Q · filed 2018-01-16 | $2.38M 10-Q · filed 2018-01-16 | ||
| 2016-08-31 | -$110.58K 10-Q · filed 2017-10-16 | |||
| 2016-02-29 | -$261.11K 10-Q · filed 2017-04-13 | $243.62K derived: sum of 2 quarters · filed 2017-04-13 | $888.14K 10-Q · filed 2017-04-13 | $743.82K derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | $504.73K 10-Q · filed 2017-01-17 | $1.15M 10-Q · filed 2017-01-17 | $1.00M derived: sum of 3 quarters · filed 2017-01-17 | $1.90M derived: sum of 4 quarters · filed 2017-01-17 |
| 2015-08-31 | $644.52K 10-Q · filed 2016-10-17 | $500.20K derived: sum of 2 quarters · filed 2016-10-17 | $1.40M derived: sum of 3 quarters · filed 2016-10-17 | $1.24M derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | -$144.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $754.31K derived: sum of 2 quarters · filed 2016-04-14 | $595.03K derived: sum of 3 quarters · filed 2016-04-14 | $146.95K 10-K · filed 2015-08-31 |
| 2015-02-28 | $898.63K 10-Q · filed 2016-04-14 | $739.34K derived: sum of 2 quarters · filed 2016-04-14 | $291.27K 10-Q · filed 2016-04-14 | -$200.64K derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | -$159.28K 10-Q · filed 2016-01-14 | -$607.36K 10-Q · filed 2016-01-14 | -$1.10M derived: sum of 3 quarters · filed 2016-01-14 | -$1.16M derived: sum of 4 quarters · filed 2016-01-14 |
| 2014-08-31 | -$448.07K 10-Q · filed 2015-10-15 | -$939.99K derived: sum of 2 quarters · filed 2015-10-15 | -$999.76K derived: sum of 3 quarters · filed 2015-10-15 | $350.64K derived: sum of 4 quarters · filed 2015-10-15 |
| 2014-05-31 | -$491.92K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | -$551.69K derived: sum of 2 quarters · filed 2015-08-31 | $798.71K derived: sum of 3 quarters · filed 2015-08-31 | $628.35K 10-K · filed 2015-08-31 |
| 2014-02-28 | -$59.78K 10-Q · filed 2015-04-14 | $1.29M derived: sum of 2 quarters · filed 2015-04-14 | $1.12M 10-Q · filed 2015-04-14 | $5.99M derived: sum of 4 quarters · filed 2015-04-14 |
| 2013-11-30 | $1.35M 10-Q · filed 2015-01-14 | $1.18M 10-Q · filed 2015-01-14 | $6.05M derived: sum of 3 quarters · filed 2015-01-14 | $4.85M derived: sum of 4 quarters · filed 2015-01-14 |
| 2013-08-31 | -$170.37K 10-Q · filed 2014-10-15 | $4.70M derived: sum of 2 quarters · filed 2014-10-15 | $3.50M derived: sum of 3 quarters · filed 2014-10-15 | $5.97M derived: sum of 4 quarters · filed 2014-10-15 |
| 2013-05-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-19 | $3.67M derived: sum of 2 quarters · filed 2014-08-19 | $6.14M derived: sum of 3 quarters · filed 2014-08-19 | $5.02M 10-K · filed 2014-08-19 |
| 2013-02-28 | -$1.20M 10-Q · filed 2014-04-14 | $1.27M derived: sum of 2 quarters · filed 2014-04-14 | $151.33K 10-Q · filed 2014-04-14 | $858.75K derived: sum of 4 quarters · filed 2014-04-14 |
| 2012-11-30 | $2.47M 10-Q · filed 2014-01-14 | $1.36M 10-Q · filed 2014-01-14 | $2.06M derived: sum of 3 quarters · filed 2014-01-14 | $1.89M derived: sum of 4 quarters · filed 2014-01-14 |
| 2012-08-31 | -$1.11M 10-Q · filed 2013-10-15 | -$406.72K derived: sum of 2 quarters · filed 2013-10-15 | -$576.67K derived: sum of 3 quarters · filed 2013-10-15 | -$2.69M derived: sum of 4 quarters · filed 2013-10-15 |
| 2012-05-31 | $707.42K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-23 | $537.46K derived: sum of 2 quarters · filed 2013-08-23 | -$1.58M derived: sum of 3 quarters · filed 2013-08-23 | -$3.64M 10-K · filed 2013-08-23 |
| 2012-02-29 | -$169.95K 10-Q · filed 2013-04-15 | -$2.29M derived: sum of 2 quarters · filed 2013-04-15 | -$4.35M 10-Q · filed 2013-04-15 | |
| 2011-11-30 | -$2.12M 10-Q · filed 2013-01-14 | -$4.18M 10-Q · filed 2013-01-14 | ||
| 2011-08-31 | -$2.07M 10-Q · filed 2012-10-15 |